Lisa A. Carey

University of North Carolina at Chapel Hill

Also affiliated with UNC Lineberger Comprehensive Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

3.5Author DataRank

Indexed papers

6in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 6 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

Nature Cancer(2022)10.1038/s43018-022-00491-x

Top 9%

2.4DataRank

Top 9%114 citations

Toshinori Hinoue, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro, Tomás Pascual +53 more

Papers

Driven by 89 papers — median percentile 34. Top paper: “Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis”.

Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

Nature Cancer(2022)10.1038/s43018-022-00491-x

Top 9%

2.4DataRank

Top 9%114 citations

Toshinori Hinoue, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro, Tomás Pascual +53 more

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

Annals of Oncology(2023)10.1016/j.annonc.2023.08.004

N/A

1.7DataRank · unranked

58 citations

Timothy Blewett, Xun Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong +24 more

Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response

NAR Cancer(2022)10.1093/narcan/zcac018

N/A

1.3DataRank · unranked

44 citations

Roberto A. Leon‐Ferre, Jason P. Sinnwell, David Zahrieh, Vera J. Suman, Filho Otto Metzger +15 more

Clinical subtype, treatment response, and survival in De Novo and recurrent metastatic breast cancer

Breast Cancer Research and Treatment(2022)10.1007/s10549-022-06700-6

N/A

1.1DataRank · unranked

27 citations

Tomás Pascual, Allison M. Deal, Amy Wheless, Charles M. Perou, Elizabeth Claire Dees +2 more

Alliance A011801 (compassHER2 RD): Postneoadjuvant T-DM1 + Tucatinib/Placebo in Patients with Residual HER2-Positive Invasive Breast Cancer

Future Oncology(2021)10.2217/fon-2021-0753

N/A

0.901DataRank · unranked

30 citations

Karla V. Ballman, Linda McCall, Anuhya Kommalapati, Tyler Zemla, Anna Weiss +12 more

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor–Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination

JAMA Oncology(2024)10.1001/jamaoncol.2023.6038

N/A

0.819DataRank · unranked

21 citations

Vera J. Suman, Souzan Sanati, Kiran Vij, Meenakshi Anurag, A. Marilyn Leitch +25 more

The molecular portraits of breast tumors are conserved across microarray platforms

UNC Libraries(2020)10.17615/bz2a-5v55

N/A

0.789DataRank · unranked

191 citations

Matthew G. Ewend, Michael Mullins, Chad Livasy, Heidi J. Hansen, Mary C. Mone +26 more

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

medRxiv(2023)10.1101/2023.03.06.23286772

Top 27%

0.742DataRank

Top 27%12 citations

Timothy Blewett, Xiangying Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong +24 more

A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation

The Lancet Oncology(2020)10.1016/s1470-2045(20)30450-2

N/A

0.650DataRank · unranked

75 citations

Valentina Guarneri, Laia Paré, Gaia Griguolo, Tomás Pascual, Maria Vittoria Dieci +34 more

Burden of lymphedema in long‐term breast cancer survivors by race and age

Cancer(2022)10.1002/cncr.34489

N/A

0.621DataRank · unranked

62 citations

Michael A. Kebede, Adeyemi A. Ogunleye, Marc A. Emerson, Kelly R. Evenson, Lisa A. Carey +3 more

Pregnancy After Breast Cancer in Young BRCA Carriers

JAMA(2024)10.1001/jama.2023.25463

N/A

0.614DataRank · unranked

59 citations

Eva Blondeaux, Elisa Agostinetto, Anne-Sophie Hamy, Hee Jeong Kim, Antonio Di Meglio +199 more

Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies

JNCI Journal of the National Cancer Institute(2022)10.1093/jnci/djac117

N/A

0.596DataRank · unranked

52 citations

Thomas U. Ahearn, Sabine Behrens, Pooja Middha, Manjeet K. Bolla, Qin Wang +66 more

Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line Chemotherapy

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa113

N/A

0.587DataRank · unranked

49 citations

Laura H. Hendrix, Terry Hyslop, William T. Barry, Eric P. Winer, Clifford A. Hudis +27 more

Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-003427

N/A

0.500DataRank · unranked

27 citations

Mark G. Woodcock, Amanda E.D. Van Swearingen, Dominic T. Moore, Maria J. Sambade, Sonia J. Laurie +22 more

Clinical Significance of Circulating Tumor Cells in Hormone Receptor–positive Metastatic Breast Cancer Patients who Received Letrozole with or Without Bevacizumab

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1329

N/A

0.483DataRank · unranked

24 citations

Oleksandr Savenkov, Erik Asmus, Karla V. Ballman, Janet H. Scott, John W. Park +6 more

FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036

npj Breast Cancer(2021)10.1038/s41523-021-00258-0

N/A

0.483DataRank · unranked

24 citations

Timothy J. Stuhlmiller, Gaurav Mehta, Samantha M. Bevill, Daniel R. Goulet, José F. Olivares-Quintero +25 more

Tamoxifen Response at Single-Cell Resolution in Estrogen Receptor–Positive Primary Human Breast Tumors

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1248

N/A

0.457DataRank · unranked

20 citations

Austin A. Whitman, Kamila Wiśniewska, Rasha T. Kakati, Susana García‐Recio, Benjamin C. Calhoun +5 more

Prognostic value of HER2DX in early-stage HER2-positive breast cancer: a comprehensive analysis of 757 patients in the Sweden Cancerome Analysis Network—Breast dataset (SCAN-B)

ESMO Open(2024)10.1016/j.esmoop.2024.102388

N/A

0.442DataRank · unranked

18 citations

Tomás Pascual, Fara Brasó‐Maristany, Laia Paré, Olga Martínez‐Sáez, Javier Cortés +15 more

Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials

Nature Communications(2023)10.1038/s41467-023-42635-2

N/A

0.434DataRank · unranked

17 citations

Aranzazu Fernández-Martínez, David Venet, Françoise Rothé, Katherine A. Hoadley, Joel S. Parker +17 more

A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer

npj Breast Cancer(2022)10.1038/s41523-022-00473-3

N/A

0.425DataRank · unranked

16 citations

Kirsten A. Nyrop, Susan L. Strum, Anne K. Knecht, Lisa A. Carey, Katherine E. Reeder‐Hayes +9 more

Research autopsy programmes in oncology: shared experience from 14 centres across the world

The Journal of Pathology(2024)10.1002/path.6271

N/A

0.425DataRank · unranked

16 citations

Marion Maetens, Jody E. Hooper, Steffi Oesterreich, Adrian V. Lee, Lori Miller +41 more

Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502

npj Breast Cancer(2024)10.1038/s41523-024-00683-x

N/A

0.419DataRank · unranked

7 citations

Roberto Salgado, Oleksander Savenkov, Karla V. Ballman, Erica L. Mayer, Mark Jesus M. Magbanua +11 more

Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials

npj Breast Cancer(2022)10.1038/s41523-022-00430-0

N/A

0.417DataRank · unranked

8 citations

Zhuo Li, Daniel Serie, Nadine Norton, Afshin Mashadi-Hossein, Kathleen Tenner +20 more

Palbociclib in adults aged 70 years and older with advanced breast cancer: A phase 2 multicenter trial (Alliance A171601)

Journal of Geriatric Oncology(2024)10.1016/j.jgo.2024.101813

N/A

0.402DataRank · unranked

7 citations

Minji K. Lee, Jingran Ji, Daniel Satele, Rachel A. Freedman, Philip D. Poorvu +12 more

Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status

Cancer Epidemiology Biomarkers & Prevention(2024)10.1158/1055-9965.epi-23-1201

N/A

0.385DataRank · unranked

12 citations

Matthew R. Dunn, Alina M. Hamilton, Joannie M. Ivory, Xiaohua Gao, Erin L. Kirk +10 more

Obesity and Breast Cancer Metastasis across Genomic Subtypes

Cancer Epidemiology Biomarkers & Prevention(2022)10.1158/1055-9965.epi-22-0013

N/A

0.373DataRank · unranked

11 citations

Andrea Walens, Alina M. Hamilton, Halei C. Benefield, Jodie M. Fleming, Lisa A. Carey +4 more

Effect of a telephone-based weight loss intervention (WLI) on weight at 12-months in women with early breast cancer: Results from the Breast Cancer Weight Loss (BWEL) trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12001

N/A

0.360DataRank · unranked

10 citations

Karla V. Ballman, Linda McCall, Pamela J. Goodwin, Anna Weiss, Linda M. Delahanty +15 more

Adjuvant Dose-Dense Chemotherapy in Hormone Receptor–Positive Breast Cancer

Journal of Clinical Oncology(2025)10.1200/jco-24-01875

N/A

0.319DataRank · unranked

6 citations

Karla V. Ballman, Jordan D. Campbell, Minetta C. Liu, Jennifer A. Ligibel, Mark A. Watson +12 more

A latent class assessment of healthcare access factors and disparities in breast cancer care timeliness

PLoS Medicine(2024)10.1371/journal.pmed.1004500

N/A

0.312DataRank · unranked

7 citations

Didong Li, Marc A. Emerson, Caroline A. Thompson, Hazel B. Nichols, Sarah C. Van Alsten +7 more

Stain SAN: simultaneous augmentation and normalization for histopathology images

Journal of Medical Imaging(2024)10.1117/1.jmi.11.4.044006

N/A

0.269DataRank · unranked

5 citations

Yao Li, Benjamin C. Calhoun, Aatish Thennavan, Lisa A. Carey, W. Fraser Symmans +4 more

Differences in 21-Gene and PAM50 Recurrence Scores in Younger and Black Women With Breast Cancer

JCO Precision Oncology(2024)10.1200/po.24.00137

N/A

0.241DataRank · unranked

4 citations

Sanah Vohra, Joannie M. Ivory, Alina M. Hamilton, Xiaohua Gao, Erin L. Kirk +7 more

Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkers

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102154

N/A

0.212DataRank · unranked

3 citations

Aranzazu Fernandez-Martinez, Tanmayi D. Vashist, Matthew V. Holt, LaTerrica Williams, Jonathan T. Lei +26 more

Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC)

Annals of Oncology(2024)10.1016/j.annonc.2024.12.010

N/A

0.208DataRank · unranked

3 citations

Maki Tanioka, Sung Gwe Ahn, Paola Zagami, Tomás Pascual, Mattia Rediti +18 more

Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains

UNC Libraries(2020)10.17615/vnt3-7a98

N/A

0.208DataRank · unranked

3 citations

Jon S. Zawistowski, Lisa A. Carey, Rachel A. Reuther, Kazuhiro Nakamura, Steven P. Angus +15 more

Association of tumor infiltrating lymphocyte quantity with survival in patients (pts) with metastatic breast cancer (MBC) receiving microtubule-targeting agents: Post hoc analysis CALGB 40502 (Alliance).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1010

N/A

0.203DataRank · unranked

2 citations

Roberto Salgado, Oleksandr Savenkov, Karla V. Ballman, Mark Jesus M. Magbanua, Sherene Loi +11 more

Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing

UNC Libraries(2020)10.17615/vr6a-dp31

Top 66%

0.190DataRank

Top 66%1 citations

Morris Weinberger, Katherine E. Reeder‐Hayes, Melissa A. Troester, Stacie B. Dusetzina, Michaela A. Dinan +3 more

Quantitative proteomic mass spectrometry of protein kinases to determine dynamic heterogeneity of the human kinome

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.10.04.614143

N/A

0.181DataRank · unranked

2 citations

Robert W. Sprung, Denis O. Okumu, José F. Olivares-Quintero, Chinmaya U. Joisa, Xin Chen +21 more

Kinase Plasticity with Vandetanib Treatment Enhances Sensitivity to Tamoxifen in Estrogen Receptor Positive Breast Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.12.19.629395

N/A

0.174DataRank · unranked

2 citations

Rasha T. Kakati, Santiago Haase, Christine Thai, Attila Szénási, Elizabeth Brunk +10 more

Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017

Cancer(2023)10.1002/cncr.35078

Top 67%

0.171DataRank

Top 67%2 citations

Shaylene McCue, Jun He, Jacqueline M. Lafky, Lisa A. Carey, Evanthia Galanis +9 more

Snord67 promotes lymph node metastasis and regulates U6-mediated alternative splicing in breast cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.08.28.272617

N/A

0.165DataRank · unranked

2 citations

Yinzhou Zhu, Hannah J. Wiedner, Yi‐Hsuan Tsai, Lily Wilkinson, Alessandro Porrello +6 more

Multiplatform Analysis of Primary and Metastatic Breast Tumors from the AURORA US Network identifies microenvironment and epigenetics drivers of metastasis

Research Square(2022)10.21203/rs.3.rs-1221704/v1

N/A

0.165DataRank · unranked

2 citations

Susana García‐Recio, Toshinori Hinoue4, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro +49 more

A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer

medRxiv(2022)10.1101/2022.02.10.22270086

N/A

0.104DataRank · unranked

1 citations

Kirsten A. Nyrop, Susan L. Strum, Anne K. Knecht, Lisa A. Carey, Katherine E. Reeder‐Hayes +9 more

Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple Metastases

UNC Libraries(2020)10.17615/6818-b214

N/A

0.104DataRank · unranked

1 citations

Richard K. Wilson, Marni B. Siegel, Katherine A. Hoadley, Krishna Kanchi, Xiaping He +10 more

Race and smoking status associated with paclitaxel drug response in patient-derived lymphoblastoid cell lines

Pharmacogenetics and Genomics(2020)10.1097/fpc.0000000000000419

N/A

0.104DataRank · unranked

1 citations

Tammy M. Havener, Daniel L. Hertz, Jeremy R. Ash, Alexandra Larson, Lisa A. Carey +3 more

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor–Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination

UNC Libraries(2024)10.17615/41px-cd59

N/A

0.104DataRank · unranked

1 citations

Travis Dockter, Amy Tiersten, Matthew J. Ellis, Kelly K. Hunt, Wajeeha Razaq +25 more

Clinical Subtype, Treatment Response, and Survival in De Novo and Recurrent Metastatic Breast Cancer

Research Square(2022)10.21203/rs.3.rs-1479039/v1

N/A

0DataRank · unranked

0 citations

Tomás Pascual, Allison M. Deal, Amy Wheless, Charles M. Perou, E. Claire Dees +2 more

A single-arm feasibility trial of memantine to prevent chemotherapy-related cognitive decline in patients with early breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.12109

N/A

0DataRank · unranked

0 citations

Allison M. Deal, Eliza Myung Park, Kate E. Stanton, Yesy E. Lopez, Laura J. Quillen +14 more

Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor–positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials

UNC Libraries(2021)10.17615/0xpa-s139

N/A

0DataRank · unranked

0 citations

E. Carrasco, C. Hudis, S. Morales, C.T. Cirrincione, GBG +20 more

Investigating survivin as a novel target in black women with breast cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.594

N/A

0DataRank · unranked

0 citations

Linnea T. Olsson, Sarah Van Alsten, Lisa A. Carey, Melissa A. Troester, Yara Abdou +1 more

Age, Body Mass Index, Tumor Subtype, and Racial and Ethnic Disparities in Breast Cancer Survival

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.39584

N/A

0DataRank · unranked

17 citations

Karla V. Ballman, Jordan D. Campbell, Hyman B. Muss, Edith A. Perez, Lawrence N. Shulman +4 more

Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer

UNC Libraries(2020)10.17615/yge2-qn91

N/A

0DataRank · unranked

0 citations

Allison M. Deal, Sumit Rawal, David B. Darr, Carey K. Anders, William C. Zamboni +10 more

Epidemiology of basal-like breast cancer (Breast Cancer Research and Treatment DOI: 10.1007/s10549-007-9632-6)

UNC Libraries(2020)10.17615/2kpx-j447

N/A

0DataRank · unranked

0 citations

Susan Jackson, Chiu Kit Tse, Sarah J. Nyante, Charles M. Perou, Patricia G. Moorman +10 more

The Use of Bayesian Hierarchical Models for Adaptive Randomization in Biomarker-Driven Phase II Studies

UNC Libraries(2020)10.17615/8tqa-vs28

N/A

0DataRank · unranked

0 citations

Joseph G. Ibrahim, Charles M. Perou, Lisa A. Carey, P. Kelly Marcom, William T. Barry

CYP2C8*3 predicts benefit/risk profile in breast cancer patients receiving neoadjuvant paclitaxel

UNC Libraries(2020)10.17615/cyk5-ch98

N/A

0DataRank · unranked

0 citations

Stacey J. Winham, Howard L. McLeod, E. Claire Dees, Amy Drobish, Daniel L. Hertz +2 more

Disparities in Use of Human Epidermal Growth Hormone Receptor 2–Targeted Therapy for Early-Stage Breast Cancer

UNC Libraries(2020)10.17615/np0a-cy70

N/A

0DataRank · unranked

0 citations

Lisa A. Carey, Ke Meng, Stacie B. Dusetzina, Sharon Peacock Hinton, Katherine E. Reeder‐Hayes

Data from Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolina Breast Cancer Study

(2023)10.1158/1078-0432.c.6519519.v1

Top 100%

0DataRank

Top 100%0 citations

Stephen R. Cole, Chiu‐Kit Tse, Charles M. Perou, Lisa A. Carey, William D. Foulkes +4 more

Blood Vessel Morphologic Changes Depicted with MR Angiography during Treatment of Brain Metastases: A Feasibility Study

UNC Libraries(2020)10.17615/50wc-6m30

N/A

0DataRank · unranked

0 citations

J. Keith Smith, Matthew G. Ewend, Donglin Zeng, Eric P. Winer, Weili Lin +3 more

Effect of Cytotoxic Chemotherapy on Markers of Molecular Age in Patients With Breast Cancer

UNC Libraries(2020)10.17615/d7ht-d843

N/A

0DataRank · unranked

0 citations

Brittaney-Belle Gordon, Hanna K. Sanoff, Chad Torrice, K. Lenhard Rudolph, Amy Drobish +13 more

A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer

UNC Libraries(2020)10.17615/01wd-2j16

N/A

0DataRank · unranked

0 citations

Matthias W. Beckmann, Federico Canzian, Dimopoulos, Athanasios M, Leslie Bernstein, Jenny Chang‐Claude +27 more

Chemotherapy-related amenorrhea after adjuvant paclitaxel–trastuzumab (APT trial)

UNC Libraries(2020)10.17615/e33z-ag80

N/A

0DataRank · unranked

0 citations

Harold J. Burstein, Lisa A. Carey, Antonio C. Wolff, Sara M. Tolaney, P. Kelly Marcom +15 more

Engaging in Health Behaviors to Lower Risk for Breast Cancer Recurrence

UNC Libraries(2020)10.17615/v4nm-qr70

N/A

0DataRank · unranked

0 citations

Lisa A. Carey, Alice R. Richman, Suzanne C. O’Neill, Noel T. Brewer, Jessica T. DeFrank +2 more

TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer

UNC Libraries(2020)10.17615/yrss-qx89

N/A

0DataRank · unranked

0 citations

Charles M. Perou, Madlyn Ferraro, Mothaffar F. Rimawi, Wing‐Keung Chiu, Antonio C. Wolff +15 more

Phase II Study of Bortezomib and Pegylated Liposomal Doxorubicin in the Treatment of Metastatic Breast Cancer

UNC Libraries(2020)10.17615/wwde-9r73

N/A

0DataRank · unranked

0 citations

Frances A. Collichio, Philip S. Bernard, Robert Z. Orlowski, Inge J. Stijleman, Anastasia Ivanova +5 more

Incorporating external controls in the design of randomized clinical trials: a case study in solid tumors

BMC Medical Research Methodology(2024)10.1186/s12874-024-02383-3

N/A

0DataRank · unranked

3 citations

Jiawen Zhu, Herbert Pang, Xiao Li, Yinqi Zhao, Evan Kwiatkowski +3 more

Nodal Response and Survival After Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive Breast Cancer: 20-Year Experience from a Single Institution

Annals of Surgical Oncology(2024)10.1245/s10434-024-16059-1

N/A

0DataRank · unranked

5 citations

Christine Thai, Sherin Ismail, Chris B. Agala, Van T. Hoang, Timothy Feeney +8 more

Phase II Trial of Lapatinib for Brain Metastases in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

UNC Libraries(2020)10.17615/7w8k-g207

N/A

0DataRank · unranked

0 citations

Ann Crawford, Annick D. Van den Abbeele, Rebecca Gelman, Steven E. Come, Xiaochun Li +13 more

Altered-Function p53 Missense Mutations Identified in Breast Cancers Can Have Subtle Effects on Transactivation

UNC Libraries(2020)10.17615/eb41-zn06

N/A

0DataRank · unranked

0 citations

Michael A. Resnick, Alberto Inga, Jennifer Jordan, Kathleen Conway, Lin Wu +2 more

A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina Experience

UNC Libraries(2020)10.17615/xty4-wk68

N/A

0DataRank · unranked

0 citations

E. Claire Dees, Amy Garrett, Matthew G. Ewend, Timothy M. Zagar, Megan Jean McKee +7 more

Patient‐reported persistent lymphedema and peripheral neuropathy among long‐term breast cancer survivors in the Carolina Breast Cancer Study

Cancer(2024)10.1002/cncr.35650

N/A

0DataRank · unranked

2 citations

Hazel B. Nichols, Qichen Wang, Rachel Hirschey, Erin E. Kent, Lisa A. Carey +5 more

ABC trial (A011502): A randomized phase III double-blinded placebo-controlled trial of aspirin as adjuvant therapy breast cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps600

N/A

0DataRank · unranked

5 citations

Eric P. Winer, Karla V. Ballman, Ann H. Partridge, Lisa A. Carey, Margaret Carvan +6 more

Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib

UNC Libraries(2020)10.17615/6adk-r027

N/A

0DataRank · unranked

0 citations

Carey K. Anders, Charles M. Perou, Ian E. Krop, Constance Cirrincione, Brandelyn N. Pitcher +13 more

Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II–III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance)

UNC Libraries(2020)10.17615/3qn5-sn85

N/A

0DataRank · unranked

0 citations

Lisa A. Carey, Beth Overmoyer, Constance Cirrincione, William M. Sikov, Mehra Golshan +9 more

Incorporating external controls in the design of randomized clinical trials: a case study in solid tumors

UNC Libraries(2024)10.17615/0cbt-p942

N/A

0DataRank · unranked

0 citations

Herbert Pang, Xiao Li, Lisa A. Carey, Emily Damone, Joseph G. Ibrahim +3 more

A latent class assessment of healthcare access factors and disparities in breast cancer care timeliness.

UNC Libraries(2024)10.17615/j79h-c055

N/A

0DataRank · unranked

0 citations

Matthew R. Dunn, Marc A. Emerson, Lisa A. Carey, Mya L. Roberson, Caroline A. Thompson +7 more

Snord67 promotes breast cancer metastasis by guiding U6 modification and modulating the splicing landscape

Nature Communications(2025)10.1038/s41467-025-59406-w

N/A

0DataRank · unranked

4 citations

Katherine I. Zhou, Kwame Forbes, Alessandro Porrello, Gabrielle M. Gentile, Yinzhou Zhu +18 more

A phase I and pharmacologic study of the combination of bortezomib and pegylated liposomal doxorubicin in patients with refractory solid tumors

UNC Libraries(2020)10.17615/gmbp-hs07

N/A

0DataRank · unranked

0 citations

Celeste Lindley, Frances A. Collichio, Lisa A. Carey, Bert H. O’Neil, E. Claire Dees +5 more

TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases

UNC Libraries(2020)10.17615/bgrr-9v25

N/A

0DataRank · unranked

0 citations

Anna Maria Storniolo, Vered Stearns, Vandana G. Abramson, Joel S. Parker, Catherine Van Poznak +19 more

Assessment of the functional and health-related needs of patients with metastatic breast cancer prior to initiation of cancer treatment

Breast Cancer Research and Treatment(2025)10.1007/s10549-024-07590-6

N/A

0DataRank · unranked

2 citations

Alexis C. Wardell, Carley Bailey, Brianna Connelly, Lisa A. Carey, William A. Wood +3 more

Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response

UNC Libraries(2025)10.17615/h225-mq92

N/A

0DataRank · unranked

0 citations

Daniel G. Stover, David Zahrieh, Matthew P. Goetz, Eric W. Klee, Lisa A. Carey +15 more

Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors.

UNC Libraries(2025)10.17615/3745-y008

N/A

0DataRank · unranked

0 citations

E Claire Dees, Dominic T. Moore, Lisa M. Bixby, Danielle M. File, Shannon Reisdorf +13 more

A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer

UNC Libraries(2025)10.17615/ke73-zr05

N/A

0DataRank · unranked

0 citations

Trevor A. Jolly, Lisa A. Carey, Anne K. Knecht, E. Claire Dees, Erin A. O’Hare +9 more

Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials

UNC Libraries(2025)10.17615/kfcn-nf74

N/A

0DataRank · unranked

0 citations

Afshin Mashadi-Hossein, Kathleen Tenner, Lisa A. Carey, Zhuo Li, Heather Ann Brauer +20 more

Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status.

UNC Libraries(2025)10.17615/8a1s-r359

N/A

0DataRank · unranked

0 citations

Terry Hyslop, Alina M. Hamilton, Erin L. Kirk, Sarah C. Van Alsten, Yara Abdou +10 more

Interferon signaling and outcomes in triple-negative breast cancer (TNBC) in FinXX, CALGB 40603 (Alliance) and real-world clinico-genomic data.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.569

N/A

0DataRank · unranked

0 citations

Yi Liu, Sachin Kumar Deshmukh, Jodi M. Carter, Heikki Joensuu, Roberto A. Leon‐Ferre +15 more

Associations between social drivers of health and breast cancer stage at diagnosis among U.S. Black women

npj Breast Cancer(2025)10.1038/s41523-025-00804-0

N/A

0DataRank · unranked

0 citations

Bo Qin, Marc A. Emerson, Etienne X. Holder, Matthew R. Dunn, Shromona Sarkar +21 more

Integration of Gene Expression and Digital Histology to Predict Treatment-Specific Responses in Breast Cancer

medRxiv(2025)10.1101/2025.08.25.25334393

N/A

0DataRank · unranked

0 citations

James M. Dolezal, Hanna M. Hieromnimon, Sara J. Venters, Sara Kochanny, Anran Li +31 more

Differences in 21-Gene and PAM50 Recurrence Scores in Younger and Black Women With Breast Cancer

UNC Libraries(2025)10.17615/4e5p-rq23

N/A

0DataRank · unranked

0 citations

Erin L. Kirk, Sanah Vohra, Eboneé N. Butler, Melissa A. Troester, Katherine A. Hoadley +7 more

Patient‐reported persistent lymphedema and peripheral neuropathy among long‐term breast cancer survivors in the Carolina Breast Cancer Study

UNC Libraries(2025)10.17615/w43m-2610

N/A

0DataRank · unranked

0 citations

Adeyemi A. Ogunleye, Qichen Wang, Rina Yarosh, Erin E. Kent, Eboneé N. Butler +5 more

A randomized phase III, double-blinded, placebo-controlled trial of aspirin as adjuvant therapy for breast cancer (A011502): The Aspirin after Breast Cancer (ABC) Trial

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.36_suppl.360922

N/A

0DataRank · unranked

16 citations

Karla V. Ballman, Eric P. Winer, Thomas H. Openshaw, Olwen Hahn, Frederick Briccetti +10 more

Lisa A. Carey

Indexed papers

Top data-sharing exemplar

Papers